SCHEDULE 13G/A
Statement of Beneficial Ownership
Contineum Therapeutics, Inc. Filed Acc 0000950170-25-072735
Stakes reported in this filing
Stake history · largest stake in each 13D and 13G
Loading xslSCHEDULE_13G_X01/primary_doc.xml…